Olopatadine Hydrochloride and Mometasone Furoate Monohydrate
Adults and adolescents 12 years of age and older for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis.
Ear nose and oropharynx
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria